BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11753159)

  • 1. Erythromycin as a prokinetic agent in preterm infants.
    Costalos C; Gounaris A; Varhalama E; Kokori F; Alexiou N; Kolovou E
    J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):23-5. PubMed ID: 11753159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of low-dose erythromycin on whole gastrointestinal transit time of preterm infants.
    Costalos C; Gavrili V; Skouteri V; Gounaris A
    Early Hum Dev; 2001 Dec; 65(2):91-6. PubMed ID: 11641030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of erythromycin on gastroduodenal contractile activity in developing neonates.
    Jadcherla SR; Berseth CL
    J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):16-22. PubMed ID: 11753158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial of cisapride in preterm infants.
    McClure RJ; Kristensen JH; Grauaug A
    Arch Dis Child Fetal Neonatal Ed; 1999 May; 80(3):F174-7. PubMed ID: 10212076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin as a prokinetic agent.
    Kaul A
    J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):13-5. PubMed ID: 11753157
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants.
    ElHennawy AA; Sparks JW; Armentrout D; Huseby V; Berseth CL
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):281-6. PubMed ID: 12960650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC; So KW; Fung KS; Lee CH; Fok TF; Wong E; Wong W; Cheung KL; Cheng AF
    Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F177-82. PubMed ID: 11320044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral erythromycin for treatment of feeding intolerance in preterm infants: a preliminary report.
    Sekteera W; Nuntnarumit P; Supapannachart S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1177-82. PubMed ID: 12549792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC
    Neonatology; 2009; 95(2):97-104. PubMed ID: 19218823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin and feeding intolerance in premature infants: a randomized trial.
    Aly H; Abdel-Hady H; Khashaba M; El-Badry N
    J Perinatol; 2007 Jan; 27(1):39-43. PubMed ID: 17036029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin for feeding intolerance in preterm infants.
    Ng E; Shah V
    Cochrane Database Syst Rev; 2001; (2):CD001815. PubMed ID: 11406010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin increases gastric antral motility in human premature infants.
    Tomomasa T; Miyazaki M; Koizumi T; Kuroume T
    Biol Neonate; 1993; 63(6):349-52. PubMed ID: 8373908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythromycin for feeding intolerance in preterm infants.
    Ng E; Shah V
    Cochrane Database Syst Rev; 2000; (2):CD001815. PubMed ID: 10796273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrolysed protein accelerates the gastrointestinal transport of formula in preterm infants.
    Mihatsch WA; Högel J; Pohlandt F
    Acta Paediatr; 2001 Feb; 90(2):196-8. PubMed ID: 11236051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythromycin as a prokinetic agent in preterm neonates: a systematic review.
    Patole S; Rao S; Doherty D
    Arch Dis Child Fetal Neonatal Ed; 2005 Jul; 90(4):F301-6. PubMed ID: 15899929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants.
    Oei J; Lui K
    Acta Paediatr; 2001 Aug; 90(8):904-8. PubMed ID: 11529540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral erythromycin on fasting and postprandial antroduodenal motility in patients with type I diabetes, measured with an ambulatory manometric technique.
    Samsom M; Jebbink RJ; Akkermans LM; Bravenboer B; vanBerge-Henegouwen GP; Smout AJ
    Diabetes Care; 1997 Feb; 20(2):129-34. PubMed ID: 9118759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of erythromycin on bile excretion and proximal small bowel motility following divided gastric bypass surgery: a prospective randomized placebo-controlled trial.
    Wilkinson NW; Gustafson RJ; Frizzi JD
    Obes Surg; 2002 Dec; 12(6):765-72. PubMed ID: 12568180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.
    Ng E; Shah VS
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001815. PubMed ID: 18646077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants.
    Mansi Y; Abdelaziz N; Ezzeldin Z; Ibrahim R
    Neonatology; 2011; 100(3):290-4. PubMed ID: 21701222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.